期刊文献+

重症肌无力P9-ZFD蛋白的骨骼肌亚细胞定位 被引量:1

Subcellular localization of skeletal muscle P9-ZFD protein in myasthenia gravis
下载PDF
导出
摘要 目的 :表达、纯化重症肌无力相关P9基因TRAF型锌指结构 (P9TRAF typezincfingerdomain ,简称P9 ZFD)编码的蛋白质 ,制备P9 ZFD多克隆抗体 ,研究P9 ZFD蛋白的骨骼肌亚细胞定位。 方法 :应用逆转录 聚合酶链反应 (RT PCR )克隆编码P9 ZFD的cDNA序列 ,构建pET2 4a P9 ZFD表达载体 ,在E .coliBL2 1(DE3)中胞内诱导表达P9 ZFD蛋白 ,组氨酸亲和色谱法纯化P9 ZFD蛋白并免疫Balb/c小鼠制备其多克隆抗体。ELISA和Westernblot鉴定抗体效价及其免疫特异性。免疫组织化学及免疫电镜观察P9 ZFD蛋白在骨骼肌中的表达部位及其亚细胞分布。结果 :表达、纯化的P9 ZFD蛋白相对分子质量约 30kD ,纯度达 95 %以上。制备的P9 ZFD抗体具有特异的免疫反应性。免疫组织化学和免疫电镜结果显示 ,P9 ZFD蛋白的免疫染色部位集中沿MG骨骼肌细胞膜分布。结论 :重症肌无力相关的P9 ZFD蛋白在MG骨骼肌细胞膜处表达 ,是一种骨骼肌细胞膜蛋白组分。 Objective: To express and purify the protein encoding the TRAF-type zinc finger domain of myastheniagravis ( MG ) related gene P9 ( P9-ZFD ) and to prepare P9-ZFD polyclonal antibody for studying subcellular localization of P9-ZFD protein in skeletal muscle. Methods: The cDNA fragment encoding P9-ZFD was amplified by RT-PCR. The cloned P9-ZFD cDNA fragment was ligated into the expression vector pET-24a, and the P9-ZFD recombinant protein was induced via E.coli BL21(DE3)and purified by histidine affinity chromatography. P9-ZFD antibody was prepared through immunizing Balb/c rats with purified P9-ZFD protein. Its titer and specificity were determined with ELISA and Western blot. Subcellular distribution of skeletal muscle P9-ZFD protein was studied with immunohistochemitry and immunoelectron microscopy. Results:The molecular weight of purified P9-ZFD protein was about 30 kD. Its purity was more than 95 percent. The antibody was specific for P9-ZFD protein. Immunostaining of P9-ZFD protein distributed along cellular membrane of skeletal muscle of MG. Conclusion: P9-ZFD protein was expressed in cellular membrane of skeletal muscle. It should be a membrane component.
出处 《中国神经科学杂志》 CSCD 2003年第5期308-312,共5页
基金 国家自然科学基金资助项目 (3 0 0 70 716)
关键词 重症肌无力 P9-ZFD蛋白 骨骼肌亚细胞定位 制备 逆转录-聚合酶链反应 CDNA序列 myasthenia gravis skeletal muscle P9-ZFD gene fragment P9-ZFD antibody immunoelectron microscopy
  • 相关文献

参考文献9

  • 1武勇琴,吕传真,周天华,杨茹,乔健,马兰,裴钢.应用差别显示聚合酶链反应筛选及鉴定重症肌无力相关基因[J].中华神经科杂志,1998,31(2):69-71. 被引量:14
  • 2周志刚,卢家红,任惠民,武勇琴,吕传真.重症肌无力患者相关基因差异片段P2和P9的分布研究[J].中华医学杂志,2000,80(10):760-761. 被引量:6
  • 3Liyange Y, Hoch W, Beeson D, et al. The agrin/muscle-specific kinase pathway: new targets for autoimmune and genetic disorders at the neuromuscular junction [ J ]. Muscle Nerve, 2002, 25 : 4-16.
  • 4Vincent A, Palace J, Hilton-Jones D. Myasthenia gravis[ J]. Lancet, 2001, 357: 2122-2128.
  • 5Asher O, Fuchs S, Zuk D, et al. Changes in the expression of mRNAs for myogenic factors and other muscle-specific proteins in experimental autoimmune myasthenia gravis [ J ]. FEBS Lett,1992,299 : 15-18.
  • 6Asher O, Kues WA, Witzemann V, et al. Increased gene expression of acetylcholine receptor and myogenic factors in passively transferred experimental autoimmune myasthenia gravis[ J]. J Immunol, 1993,151 : 6442-6450.
  • 7Sandrine P, Thierry G, Philippe L, et al.Expression of ciliary neurotrophic factor receptor in myasghenia gravis[ J ]. J Immunol,2001,120: 180-189.
  • 8Bradley JR, Pober JS. Tumor necrosis factor receptor-associated factors( TRAFs )[J]. Oncogene, 2001,20: 6482-6491.
  • 9Bongioanni P, Ricciardi R,Pellegrino D,et al T-cell tumor necrosis factor-a receptor binding in myasthenic patients[ J]. J Neuroimmunol,1999,93 : 203-207.

二级参考文献2

共引文献15

同被引文献1

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部